Padoa secures growth equity investment from Thoma Bravo
What's the deal? Padoa, the European leader in occupational health, safety, and prevention software, has secured a growth equity investment from Thoma BravoDealroom has a profile for this one. Try Dealroom →, the world's largest software-focused investment firm.
The deal runs through Thoma Bravo's €1.8 billion Europe Fund. Padoa's co-founders and existing shareholders — Five ArrowsDealroom has a profile for this one. Try Dealroom →, the alternative assets arm of Rothschild & CoDealroom has a profile for this one. Try Dealroom →, and Kamet VenturesDealroom has a profile for this one. Try Dealroom → — also took part.
The Paris-based company builds a prevention platform for occupational health centres, employers, and employees, helping them deliver services and stay compliant with tightening regulations.
Why now? Padoa wants to scale during what chief executive officer Cédric Mathorel called "one of the most significant technological shifts our industry has ever experienced" — the rise of AI.
The funds will back AI features, customer service, product work, and international expansion, especially in the DACH region.
The signal: The deal underscores how late-stage European software firms are becoming prime targets for global buyout houses chasing AI-driven growth. For Padoa, classed by Dealroom as a late-stage company, the renewed backing of Five Arrows and Kamet Ventures alongside Thoma Bravo signals investor conviction in occupational health as a niche ripe for technological disruption.
Read more: Thoma Bravo
Image credit: Generated with Gemini
